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Previous research suggests that patient-reported outcomes plateau by one year after total knee 
replacement (TKR). Analysis of trajectories to date has predominately been based on changes 
in median/mean scores over the first post-operative year, rather than variability in trajectory 
patterns over the longer-term. The aim was to evaluate variability in long-term pain and 
function trajectories after TKR.  
Hypothesis  
There will be variability in long-term pain and function trajectories after TKR. 
Patients and Methods 
266 patients undergoing a Triathlon® TKR because of osteoarthritis were recruited from one 
orthopaedic centre. Participants completed the WOMAC Pain and Function scales 
preoperatively and then at 3 months, 1 year, 2 years, 3 years, 5 years and 7 years post-
operative. Longitudinal analyses evaluated patterns of clinically meaningful change. 
Results 
Most patients had an improvement in pain and function during the first year post-operative; 
improvement was greatest in the first 3 months. By 1 year post-operative, 8% of patients had 
no change or a worsening of pain and 21% for function. Thereafter, approximately 15% of 
patients improved and 15% worsened between each assessment time. For those patients who 
had no change in symptoms from pre-operative to 1 year post-operative, one third had further 
improvement between one and 2 years post-operative. 
Discussion 
This study identified clinically meaningful variability in long-term outcomes after TKR, 
which could be discussed with patients to ensure they have realistic expectations of their 
outcome. Further research is needed to evaluate determinants of this variability and whether 
patients who will do poorly can be identified early in their recovery pathway.  
Level of evidence 
IV, prospective cohort study 
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Total knee replacement (TKR) is a common elective operation, with more than 100,000 
primary TKRs performed annually in the National Health Service [1, 2]. In the past, the 
length of time an implant remained in situ was the key indicator of a successful outcome, 
although it is now accepted that success should incorporate evaluation of patient-reported 
outcomes [3]. The most important expectations for patients electing to undergo TKR are 
improvements in pain and function [4] yet research has established that 10-34% of patients 
experience chronic pain, 20-30% patients have long-term functional limitations after TKR [5, 
6]. Most patients are aware of their TKR as an artificial joint [7] and 30% are dissatisfied 
with their outcome after TKR [8]. Informing patients of this before surgery could help 
patients form realistic expectations of outcomes.  
Previous research evaluating recovery trajectories after TKR has established that most 
improvement in pain and function occurs in the first 3 months post-operative, then further 
small improvement up to 1 year post-operative, after which outcomes plateau [9-18]. 
However, a limited number of studies have evaluated longer-term trajectories[19, 20], with 
most research evaluating patients up to 1 year post-operative. With limited research assessing 
patient-reported outcomes beyond 1 year after surgery, it is difficult to give patients a 
realistic expectation of long-term trajectories. Also, analysis of trajectories to date has 
predominately been based on median/mean scores over time, which provides limited 
information on variability in trajectory patterns over time. Using minimally clinically 
important differences (MCIDs) can provide further information on whether patients have a 
meaningful improvement or worsening in their symptoms over time [21]. Further information 
on likely individual patient recovery trajectories and variability in trajectory patterns would 
enable more detailed information to be provided to patients. The aim of this study was to 
evaluate the variability in long-term pain and functional outcome trajectories after primary 
TKR using MCIDs. The hypothesis was that there would be variability in long-term pain and 
function trajectories after TKR. 
 
 
PATIENTS AND METHODS 





These analyses use data from an ongoing cohort study which is evaluating the long-term 
outcomes of the Triathlon ® (Stryker, Limerick, Ireland) TKR. Reporting of this cohort study 
follows guidance from the STROBE initiative and a checklist ( see electronic appendix 1).  
 
Patients 
Over a three year period from October 2006 to October 2009, consecutive patients were 
approached from pre-operative assessment clinics of 11 consultant orthopaedic surgeons at 
the Avon Orthopaedic Centre, Bristol; an elective orthopaedic centre in the UK. Inclusion 
criteria were patients listed for a primary Triathlon® TKR because of osteoarthritis. 
Exclusion criteria included revision TKR, inability to understand English and inability or 
unwillingness to consent to study participation. Of the 904 patients approached about the 
study, 266 patients (29%) were recruited into the cohort. 
Ethical approval was obtained from the local Research Ethics Committee (Reference: 
06/Q2002/80) and all patients provided informed, written consent. 
Surgery 
Prior to surgery, most patients had severe osteoarthritis, with 94% of participants having a 
Kellgren and Lawrence score of 3 or 4. In terms of surgical approach, 66% had a medial 
parapatellar approach, 33% had a medial subvastus and 1% a lateral parapatellar. Ninety two 
percent % of participants had a cruciate retaining prosthesis. 
Methods of assessment 
Outcome measures were collected preoperatively and then at the following post-operative 
time points: 3 months, 1 year, 2 years, 3 years, 5 years and 7 years. Ten year post-operative 
data collection is ongoing and was not included in these analyses. Assessment was by patient-
reported outcome measures (PROMs), clinical assessment and medical records review to 
evaluate complications and survivorship.  For these analyses, we used the Pain and Function 
scales of the Western Ontario McMaster University Osteoarthritis Index (WOMAC) [22]. 
The WOMAC was posted to participants for self-completion at home, and participants did 
not have access to previous questionnaire scores. The WOMAC Pain scale assesses the 
severity of knee pain when performing five daily activities and the WOMAC Function scale 




assesses the extent of functional limitations during 17 daily activities. Total scores were 
calculated and transformed to range from 0-100 (worst to best). If only one response on the 
WOMAC Pain scale or ≤3 responses on the WOMAC Function scale were missing, then 
these were substituted with the average score from the other questions, and the total score 
was calculated [22]. 
Data on sociodemographics were collected in the pre-operative questionnaire, and co-
morbidities were assessed using the Self-Administered Comorbidity Questionnaire [23]. Data 
on body mass index (BMI) were extracted from medical records 
Sample size 
This cohort study was designed to evaluate the long-term outcomes of the Triathlon ® TKR. 
Therefore, no formal sample size calculation was performed, and the sample size was 
pragmatically determined by the number of patients that consented to participate over a three 
year recruitment period. 
Statistical analysis 
The WOMAC Pain and Function scales were non-normally distributed and therefore median 
and inter-quartile ranges were used in the descriptive analyses. Change scores for each scale 
were derived from both the preoperative score and from the previous data collection 
timepoint (consecutive change scores). Consecutive change scores between one and seven 
years post-operatively, stratified by 1 year post-operative scores, were also derived.  
The range for the MCID after TKR on the WOMAC Pain and Function scales has been found 
to be between 14 and 22 points [24]. This was calculated using an anchor-based method, 
using the mean change score for patients who defined themselves as “somewhat better” at 6 
months post-operative [24]. We used the lower value (14 points) for our analysis to ensure we 
captured all variability in outcomes that was likely to be meaningful to patients. The MCIDs 
were used to categorise the change scores as follows: 
1. ‘No change’ – change score within ±MCID 
2. ‘Worse’ – change score < MCID 
3. ‘Better’ – change score > MCID 
Some participants did not complete every questionnaire and therefore predictive mean 
matching was used to impute plausible values for these missing data (25 imputed datasets). 




All WOMAC scores were included in the multiple imputation models as well as additional 
variables which may have been useful for estimating missing values (age at the time of 
surgery, gender and marital status). Imputed data were used for our main analyses and these 
were repeated on the subsample of people who responded to every questionnaire using their 
unimputed data.  
 
RESULTS 
Participants’ characteristics  
Baseline characteristics of the 266 participants are provided in Table 1. Non-participants had 
a median age of 72 years (interquartile range 64–79) and 64% were female, which was 
similar to participant demographics. By 7 years post-operative, 9 patients had had their 
primary TKR revised, 14 had withdrawn from the study and 30 were deceased, and therefore 
213 patients (80%) were eligible to be included in these analyses. A flow chart of study 
participation is provided in Figure 1.  
Longitudinal analysis: Median scores  
Median WOMAC Pain and Function scores at each assessment time are presented in 
electronic Appendix 2 The largest improvement in median scores occurred during the first 3 
months post-operative. Further small improvements were observed between 3 months and 1 
year, and then scores remained relatively stable between one and seven years post-operative.  
Longitudinal analysis: Minimal clinically important differences  
Pre-operative to post-operative changes  
The categorised change scores, based on the MCID, from pre-operative to each post-
operative timepoint are presented in Table 2 and Figure 2. As with the median score analysis, 
the largest improvements were in the first 3 months after surgery, with 79% of patients 
having a clinically important improvement in their pain and 67% a clinically important 
improvement in their function. By 1 year, this had increased slightly but there was a subgroup 
of patients who had no improvement of their symptoms; 8% for pain and 21% for function. 
Between one and seven years, the proportion of people who had improved compared with 
their pre-operative scores remained relatively stable. 
Changes between consecutive post-operative assessments  




Consecutive categorised change scores between post-operative assessments are presented in 
Table 3 and Figure 3. Between 3 months and 1 year post-operative, 9% of patients had a 
worsening of their pain score and 10% a worsening of their function score, compared with 
42% and 29% who had improvements in pain and function, respectively. Between 1 and 2 
years, the proportions of patients with improvement and worsening of these symptoms were 
approximately equal (pain: 17% worse, 15% better; function: 12% worse, 14% better) and 
remained similar for the remainder of the follow-up period to 7 years post-operative.  
Stratified post-operative trajectories  
Table 4 provides a description of consecutive categorised change scores from one to seven 
years, stratified by whether patients had an improvement or no change in their pain and 
function between pre-operative and 1 year post-operative (people who had worse symptoms 
at 1 year comprised only ~1%). This revealed further variability in outcomes based on the 
amount of improvement achieved in the first year post-operative. Of those patients who had 
no change in their pain in the first year after surgery, 42% had an improvement in pain and 
36% an improvement in function between 1 and 2 years post-operative.  
Sensitivity analysis: Comparison of imputed and unimputed results 
The results of the sensitivity analyses using unimputed data are in electronic Appendices 2-4. 
Although there were minor differences, the sensitivity analyses were generally in agreement 
with the main analyses. The median scores for the WOMAC Pain and Function scales were 
comparable with those using imputed data (electronic Appendix 2) but unimputed medians 
were slightly higher at later timepoints. Similarly, using unimputed data a slightly higher 
proportion of participants at later timepoints had a clinically meaningful improvement in their 
WOMAC Pain and Function scores (electronic Appendix 3) compared with results using 
imputed data (Table 3). Consecutive categorised change scores using unimputed data suggest 
that from one year onwards a slightly higher proportion of participants had no change in their 
symptoms (electronic Appendix 4) compared with results using imputed data (Table 4).  
 
DISCUSSION 
Our longitudinal analysis of patient trajectories revealed novel complexities and variability in 
outcomes that are not apparent with the analysis of median/mean outcomes. We found that 
42% of patients had a further clinically important improvement in pain and 29% in function 




between 3 months and 1 year post-operative. After 1 year the amount of variability plateaus, 
but there is still variability in outcome, with approximately 15% of patients improving and 
15% worsening between each assessment time. For those patients who had no clinically 
meaningful change in pain or function from pre-operative to 1 year post-operative, 
approximately one third of patients had clinically meaningful improvement between 1 and 2 
years post-operative. This confirmed our hypothesis that there would be variability in long-
term pain and function trajectories after TKR.  
Previous research evaluating long-term outcome trajectories after TKR has found that after an 
initial improvement, pain and function decline with time. A large study of over 2,000 patients 
found that a small number of patients reported no improvement or a worsening on the Oxford 
Knee Score from pre-operative to 10 years after TKR [20]. Another study using the same 
PROM observed that the maximum average score was reported at two years post-operative, 
followed by a gradual decline up to 10 years [19]. Other studies have also found a decline in 
outcomes over time, although the starting point from this decline varies from between 3 and 5 
years post-operative [25, 26]. Our key novel finding that adds to the literature is the 
quantification of longer-term variability in outcomes, highlighting the existence of small 
subgroups of patients that improve and worsen between assessment times.  
If our findings are confirmed in future studies, then they could be used to pre-operatively 
inform patients about different outcome trajectories, so that they have realistic expectations 
of their longer-term outcomes. Although our study did not explore why some patients had a 
worsening or improvement in symptoms over time, there is evidence that pre-operative status 
is a determinant of post-operative outcome [11, 16, 27]. Therefore, further research to 
evaluate pre-operative determinants of different outcome trajectories could inform pre-
operative patient education and treatment planning. In addition, our finding that a third of 
patients who had no improvement in pain or function by 1 year post-operative are likely to 
have further clinically important improvements up to 2 years post-operative could provide 
reassurance to patients that further improvements do occur for some patients who do not 
improve in the first year after surgery.  
A key strength of our study was the inclusion of regular long-term assessments to allow 
analysis of change between consecutive post-operative time points. However, our study does 
have some limitations. Patients were recruited from a single orthopaedic centre and therefore 
external validity is limited, although patient demographics were similar to those of the 




broader UK population undergoing TKR [1]. Our recruitment rate was low at 29%, likely due 
to the high participant burden of extended follow-up. As with all longitudinal studies, there 
were missing data in the sample, however the impact of this was reduced by using data 
imputation. Another limitation is with the outcomes assessment; although the WOMAC is a 
validated joint-specific PROM, it has been found to be influenced by other factors, such as 
psychological status [31] and other painful joints [32], which may have affected our findings. 
Also inclusion of other PROMs, such as the Oxford Knee Score or Knee Osteoarthritis and 
Outcome Score, would have allowed us to compare findings using different tools. Our 
approach was to evaluate results from PROMs, although there are objective assessment tools 
that can be used to evaluate function, such as accelerometery and performance tests. 
However, there is a lack of correlation between PROMs and objective assessments of 
function [29] and our use of PROMs ensured that the patients’ experiences were central to 
assessment and that assessment focussed on activities of relevance to patients. While our 
focus was on pain and function, future research could evaluate the variability in outcome 
trajectories for other important outcomes, such as social participation which has been shown 
to have a slower rate of improvement after TKR compared to physical impairment and 
activity limitations [10]. We used the MCID to define change, however, there is currently no 
consensus of the most robust methodology to apply when defining a successful outcome after 
TKR, and other methods include calculating the Patient Acceptable State, return to normal, 
and the OMERACT-OARSI responder criteria [30].  
In conclusion, this study found long-term variability in pain and function outcome 
trajectories. Research studies should, where possible, incorporate long-term follow-up to 
capture variability in outcomes over time, using a robust methodology to identify clinically 
important change. Future research is needed to understand the causes of variation in 
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Table 1: Baseline participant characteristics  
 
Characteristic Median (IQR) or number (%) 
Median age in years (IQR) 70 (62-77) 
N (%) female 169 (64%) 
Median BMI (IQR) 30 (27-35) 
Median number of co-morbidities 2 (1-3) 
N (%) married/cohabiting 171 (66%) 
N (%) white 252 (98%) 




























Table 2: Categorised change from preoperative measurements of WOMAC Pain and 
Function between 3 months and 7 years postoperatively, N=213 (imputed dataset) 








Preop to 5 
years 
Preop to 7 
years 
WOMAC - Pain Worse 2.3% 1.0% 2.0% 2.3% 1.8% 2.8% 
 No change 18.9% 8.0% 10.2% 7.7% 11.6% 12.1% 
 Improved 78.8% 91.0% 87.7% 90.0% 86.6% 85.1% 
WOMAC - Function Worse 1.8% 0.8% 1.4% 1.1% 1.6% 3.7% 
 No change 30.8% 20.8% 18.5% 21.6% 22.0% 24.8% 
 Improved 67.4% 78.3% 80.1% 77.3% 76.4% 71.5% 
* Change in WOMAC Pain and Function were categorised as follows: ‘Worse’ (change= < -
MCID), ‘No change’ (change= -MCID to +MCID), ‘Improved’ (change= > MCID) 
  




Table 3: Categorised change between consecutive measurements of WOMAC Pain and 
Function, N=213 (imputed dataset) 
 MCID* Preop to 
3 months 
3 months 
to 1 year 
1 to 2 
years 
2 to 3 
years 
3 to 5 
years 
5 to 7 
years 
WOMAC - Pain Worse 2.3% 9.3% 16.8% 15.2% 16.4% 19.2% 
 No change 18.9% 49.2% 68.4% 71.3% 67.6% 63.0% 
 Improved 78.8% 41.5% 14.8% 13.6% 16.0% 17.8% 
WOMAC - Function Worse 1.8% 9.7% 12.1% 14.2% 14.0% 18.6% 
 No change 30.8% 61.7% 73.9% 76.3% 70.5% 71.5% 
 Improved 67.4% 28.6% 13.9% 9.4% 15.5% 9.9% 
* Change in WOMAC Pain and Function were categorised as follows: ‘Worse’ (change= < -
MCID), ‘No change’ (change= -MCID to +MCID), ‘Improved’ (change= > MCID) 
  




Table 4: Categorised change between consecutive measurements of categorised 
WOMAC Pain and Function between 2 and 7 years postoperatively, stratified by 






MCID* 1 to 2 
years 
2 to 3 
years 
3 to 5 
years 
5 to 7 years 
WOMAC – Pain  No change Worse 7.0% 22.9% 17.1% 18.8% 
  No change 51.3% 65.7% 58.0% 50.0% 
  Improved 41.7% 11.3% 25.0% 31.3% 
 Improved Worse 17.8% 13.8% 16.5% 18.2% 
  No change 70.3% 72.5% 69.3% 64.9% 
  Improved 11.9% 13.7% 14.2% 16.9% 
WOMAC – Function No change Worse 3.4% 15.2% 13.5% 21.9% 
  No change 60.9% 73.0% 69.6% 66.7% 
  Better 35.7% 11.8% 16.9% 11.5% 
 Improved Worse 14.1% 14.1% 14.0% 17.1% 
  No change 77.6% 77.4% 71.0% 73.3% 
  Improved 8.3% 8.5% 15.0% 9.6% 
* Change in WOMAC Pain and Function were categorised as follows: ‘Worse’ (change= < -














Figure 1: Flow chart of study participation  
 
Figure 2: Post-operative change in WOMAC Pain and Function scores from pre-operative 
scores, categorised into worse (change= < -MCID), no change (change= -MCID to +MCID), 
or improved (change= > MCID) 
Figure 3: Post-operative change in WOMAC Pain and Function scores from previous 
timepoint, categorised into worse (change= < -MCID), no change (change= -MCID to 
+MCID), or improved (change= > MCID) 
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